2197P Prognostic value of 18F-FDG-PET for patients with malignant pleural mesothelioma treated with double immunotherapy
Thunold, S.M.H., Hernes, E., Farooqi, S.J., Mikalsen, L.T.G., Ojlert, A.K., Helland, A., Malinen, E., Haakensen, V.D.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
LBA99 First survival data from the NIPU trial: A randomised, open-label, phase II study evaluating nivolumab and ipilimumab combined with UV1 vaccination as second-line treatment in patients with malignant mesothelioma
Helland, A., Haakensen, V.D., Ojlert, A.K., Thunold, S.M.H., Nowak, A.K., Chin, W.L., Grundberg, O., Farooqi, S.J., Lund-Iversen, M., Szejniuk, W.M., Cedres Perez, S.M., Sørensen, J.B., Bjaanaes, M.M.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article